ProfileGDS4718 / 1553812_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 34% 35% 31% 40% 32% 31% 31% 35% 27% 35% 28% 34% 35% 33% 38% 36% 32% 30% 37% 22% 41% 34% 41% 27% 33% 32% 29% 19% 29% 37% 38% 29% 32% 34% 32% 29% 32% 42% 40% 33% 30% 36% 24% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7425534
GSM549102patient 115, normal, homogenized [OPG study]4.7857435
GSM549104patient 119, normal, homogenized [OPG study]4.5785431
GSM549108patient 138, normal, homogenized [OPG study]5.0780740
GSM549119patient 077, normal, homogenized [OPG study]4.6494232
GSM549133patient 032, cancer, homogenized [OPG study]4.5447531
GSM549139patient 042, cancer, homogenized [OPG study]4.5608631
GSM549099patient 107, normal, homogenized [OPG study]4.7819935
GSM549109patient 139, normal, homogenized [OPG study]4.453227
GSM549110patient 046, normal, homogenized [OPG study]4.768135
GSM549114patient 063, normal, homogenized [OPG study]4.4189528
GSM549122patient 082, normal, homogenized [OPG study]4.7040534
GSM549134patient 033, cancer, homogenized [OPG study]4.7545835
GSM549136patient 036, cancer, homogenized [OPG study]4.6102133
GSM549140patient 044, cancer, homogenized [OPG study]4.8589538
GSM549111patient 047, normal, homogenized [OPG study]4.7700536
GSM549113patient 057, normal, homogenized [OPG study]4.570832
GSM549132patient 031, cancer, homogenized [OPG study]4.5443630
GSM549137patient 038, cancer, homogenized [OPG study]4.8443337
GSM549142patient 047, cancer, homogenized [OPG study]4.3070722
GSM549100patient 110, normal, homogenized [OPG study]5.0489241
GSM549107patient 135, normal, homogenized [OPG study]4.690934
GSM549115patient 068, normal, homogenized [OPG study]4.9843241
GSM549116patient 072, normal, homogenized [OPG study]4.4076927
GSM549120patient 078, normal, homogenized [OPG study]4.6450933
GSM549131patient 030, cancer, homogenized [OPG study]4.5712932
GSM549118patient 074, normal, homogenized [OPG study]4.5015529
GSM549129patient 027, cancer, homogenized [OPG study]4.1281219
GSM549123patient 088, normal, homogenized [OPG study]4.4941529
GSM549124patient 006, cancer, homogenized [OPG study]4.9091237
GSM549126patient 015, cancer, homogenized [OPG study]4.9034938
GSM549128patient 025, cancer, homogenized [OPG study]4.4655429
GSM549103patient 117, normal, homogenized [OPG study]4.6630532
GSM549117patient 073, normal, homogenized [OPG study]4.6935134
GSM549138patient 041, cancer, homogenized [OPG study]4.6092932
GSM549141patient 045, cancer, homogenized [OPG study]4.4526629
GSM549130patient 028, cancer, homogenized [OPG study]4.6624332
GSM549101patient 111, normal, homogenized [OPG study]5.1060642
GSM549105patient 128, normal, homogenized [OPG study]5.0153640
GSM549106patient 134, normal, homogenized [OPG study]4.6442333
GSM549112patient 048, normal, homogenized [OPG study]4.5425830
GSM549125patient 011, cancer, homogenized [OPG study]4.8341736
GSM549127patient 024, cancer, homogenized [OPG study]4.2878424
GSM549135patient 035, cancer, homogenized [OPG study]4.4924530